Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Drug Intelligence & Clinical Pharmacy|November 1, 1987
Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescentH Hermesh, D Aizenberg, A Weizman, et al.
Biological Psychiatry|February 15, 1992
Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case reportH Hermesh, D Aizenberg, G Friedberg, et al.
Clinical Neuropharmacology|August 1, 1990
Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorderR Weizman, I Gil-Ad, H Hermesh, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Rich dynamics in a simplified excitable systemS Marom, A Toib, E Braun
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 1998
Interaction between duration of activity and time course of recovery from slow inactivation in mammalian brain Na+ channelsA Toib, V Lyakhov, S Marom
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? II. Olfactory quality discrimination in obsessive-compulsive disorderH Hermesh, J Zohar, A Weizman, et al.
The Journal of Clinical Psychiatry|August 1, 1989
Catatonic signs in severe obsessive compulsive disorderH Hermesh, R A Hoffnung, D Aizenberg, et al.
Harefuah|August 24, 2000
[Severe psychiatric disorders during trips to the Far East]M L Alkan, H Hermesh, B Atzmon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? I. Alternation learning in obsessive-compulsive disorder: male-female comparisonsJ Zohar, H Hermesh, A Weizman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2000
The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label studyP Dorfman-Etrog, H Hermesh, L Prilipko, et al.
Pageof 9